vortioxetine brand
Selected indexed studies
- Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed. (J Affect Disord, 2016) [PMID:26938965]
- Clinical Psychopharmacology Update: What's in a Name? Confusion Prompts Change for Vortioxetine's Brand Name. (Issues Ment Health Nurs, 2016) [PMID:27387386]
- Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder. (Curr Med Res Opin, 2020) [PMID:31990207]
_Worker-drafted node — pending editorial review._
Connections
vortioxetine brand is a side effect of
Sources
- Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed. (2016) pubmed
- The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone. (2017) pubmed
- Clinical Psychopharmacology Update: What's in a Name? Confusion Prompts Change for Vortioxetine's Brand Name. (2016) pubmed
- Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder. (2020) pubmed
- Medication Errors Prompt Brand Name Change. (2017) pubmed
- Cost per successfully treated patient for vortioxetine versus duloxetine in adults with major depressive disorder: an analysis of the complete symptoms of depression and functional outcome. (2018) pubmed